Enanta Pharmaceuticals Stock Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enanta pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enanta Pharmaceuticals Stock Performance Today - Breaking & Trending Today

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Consensus Price Target from Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the […] ....

Enanta Pharmaceuticals Stock Performance , Jpmorgan Chase Co , News Ratings For Enanta Pharmaceuticals Daily , Hermes Inc , Acadian Asset Management , Vanguard Group Inc , Analyst Recommendations For Enanta Pharmaceuticals , Enanta Pharmaceuticals Company Profile , Enanta Pharmaceuticals Inc , Enanta Pharmaceuticals , Get Free Report , Asset Management , Trexquant Investment , Get Free , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Hold" from Analysts

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. […] ....

Acadian Asset Management , Enanta Pharmaceuticals Inc , Armistice Capital , Enanta Pharmaceuticals Stock Performance , News Ratings For Enanta Pharmaceuticals Daily , Jpmorgan Chase Co , Analyst Recommendations For Enanta Pharmaceuticals , Enanta Pharmaceuticals , Institutional Investors Weigh In On Enanta Pharmaceuticals , Vanguard Group Inc , Krensavage Asset Management , Get Free Report , Asset Management , Get Free , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Hold" from Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been given an average recommendation of “Hold” by the six ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the […] ....

United States , Enanta Pharmaceuticals , Enanta Pharmaceuticals Stock Performance , News Ratings For Enanta Pharmaceuticals Daily , Enanta Pharmaceuticals Inc , Enanta Pharmaceuticals Company Profile , Jpmorgan Chase Co , Institutional Trading Of Enanta Pharmaceuticals , Analyst Recommendations For Enanta Pharmaceuticals , Yousif Capital Management , Tennessee Treasury Department , Get Free Report , Capital Management , Sigma Investments , Financial Advisors , Wisconsin Investment Board , Get Free , Enanta Pharmaceuticals Daily ,